Tanvex Biopharma(TW:6541)
NT$28.10+0.05 (+0.18%)
TW:6541
Tanvex Biopharma earnings date
NT$28.10
At close:+0.05 (+0.18%)
Want to see TW:6541 full AI Analyst Report?
Tanvex Biopharma (6541) Q2 2026 Earnings Report
TW:6541 Q2 2026 EPS Results
- Actual EPS
- -TWD 1.44
- Consensus EPS
- -TWD 1.66
- Beat/Miss
- Beat by +TWD 0.22
- One Year Ago EPS
- -TWD 1.43
TW:6541 Q2 2026 Revenue Results
- Actual Revenue
- TWD 220.44M
- Expected Revenue
- TWD 120.00M
- Beat/Miss
- Beat by +TWD 100.44M
- YoY Revenue Growth
- +370.84%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/12/2026
- Time
- Before Open
- Conference Call
- Wednesday, August 12, 2026
TW:6541 Upcoming Earnings
Tanvex Biopharma's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:6541 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | ―- | -1.6 | ― | ― |
| Nov 11, 2026 | 2026 (Q3) | ―-1.51 | -1.08 | -39.72% (-0.43) | |
| Aug 12, 2026 | 2026 (Q2) | -1.66-1.44 | -1.43 | -0.98% (-0.01) | |
| May 12, 2026 | 2026 (Q1) | -1.64-1.47 | -2.08 | 29.19% (+0.61) | |
| Mar 04, 2026 | 2025 (Q4) | -0.76-1.60 | -1.68 | 4.88% (+0.08) | |
| Nov 12, 2025 | 2025 (Q3) | ―-1.08 | -1.93 | 43.90% (+0.84) | |
| Aug 12, 2025 | 2025 (Q2) | ―-1.43 | -2.29 | 37.61% (+0.86) | |
| May 07, 2025 | 2025 (Q1) | ―-2.08 | -3.1 | 32.92% (+1.02) | |
| Mar 14, 2025 | 2024 (Q4) | ―-1.68 | -3.8 | 55.73% (+2.12) | |
| Nov 08, 2024 | 2024 (Q3) | ―-1.93 | -3.71 | 48.16% (+1.79) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
